[Clinical observations on bladder cancer--difference in clinical features with age]

Area of Science:

• Urology
• Oncology
• Geriatrics

Context:

• Transitional cell carcinoma of the bladder is a common malignancy.
• Age is a significant factor in cancer presentation and outcomes.
• Understanding age-related differences in bladder cancer is crucial for tailored treatment.

Purpose:

• To compare clinical characteristics and outcomes of bladder cancer across different age groups.
• To identify age-specific differences in tumor presentation, stage, grade, and prognosis.

Summary:

• A retrospective review of 394 bladder cancer patients analyzed clinical features and outcomes stratified by age.
• Older patients (65+) presented with more advanced tumors (higher stage, higher grade) and had lower 5-year recurrence-free survival after transurethral resection of bladder tumor (TUR-BT).
• No significant age-related differences were observed in survival post-cystectomy for high-stage/high-grade tumors, suggesting treatment effectiveness is paramount.

Impact:

• Highlights distinct clinical presentations of bladder cancer in elderly versus younger populations.
• Suggests potential for earlier detection strategies in younger individuals who delay seeking care.
• Reinforces that aggressive tumor biology, not age alone, dictates poor prognosis in advanced bladder cancer.